/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-10-08-10-50-28-575-67050e74c71f57809f6d0411.jpg)
Introduction Over the next 2 months, the DLA Piper Life Sciences Blog: Cortex will feature a series of articles providing an insight into...
Cortex - Life Sciences Insights
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-10-31-16-30-14-487-6723b096063041cc69f3284b.jpg)
On 30 October 2024, Medicines Australia (MA) formally adopted a new edition (Edition 20) of the MA Code of Conduct (MA Code), which will...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-10-31-10-07-50-942-672356f6f951b3897d445fb3.jpg)
In this two-part article, we delve into the complexities of gene editing in plants and the ongoing EU legislative debates, followed by an...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-10-29-13-54-51-534-6720e92bc744b40bba545605.jpg)
The UK's Department of Health and Social Care (DHSC) has published its "Design for Life" roadmap towards a circular approach to medtech...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-10-29-09-33-06-124-6720abd2bd0c4ffe54164f7f.jpg)
Abstract: The EU has expressly recognised the criticality of the life sciences sector by bringing pharmaceutical manufacturers, clinical...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-10-25-09-39-53-838-671b6769812529406b73c845.jpg)
As healthcare moves towards personalised and precision medicine,[2] cell and gene therapies (CGTs) have emerged as cutting-edge and...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-10-21-11-08-52-013-6716364478278c43e86dcaf7.jpg)
The 2024 Pulse of the Sector Survey conducted by Association of British HealthTech Industries (ABHI) and Centre for Process Innovation...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-10-15-12-39-21-253-670e6279c549ddd03f0c896c.jpg)
Genome editing is an immensely powerful tool which has the potential to revolutionise the life sciences, including medicine and...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-10-11-13-33-17-456-6709291d7e6e437173aaa058.jpg)
A recent review by Dr Penny Dash, known as the 'Dash Report', has identified significant failings in England's Care Quality Commission...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Document/2024-10-07-14-40-14-168-A25284_Life_Sciences_Brochure_September_English_V1_thumbnail_1.png)
Download a copy of our September monthly briefing, which covers key updates and insights in the following areas: Medicinal products;...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/5ffc38c78cb62b0af8718cd1/2022-02-17-15-45-35-482-620e6d9ff636e91518c77538.jpg)
The Spanish Ministry of Health has made public this week the draft Royal Decree establishing the conditions for the elaboration and...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-09-30-08-30-15-184-66fa61977d75dd48d5bffd06.jpg)
In recent years, there has been an upward global trend in the implementation of new legal measures aimed at addressing pay transparency....
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-09-24-08-47-44-706-66f27cb01e4f7b4b523f2289.png)
Lawyers from DLA Piper’s Life Sciences team – Veronika Appl (Austria), Petr Samec (Czech Republic), Andrzej Balicki and Jolanta Dąbrowicz...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-09-18-07-56-38-946-66ea87b6fd15f83eafe2012f.jpg)
Resolution 2,386/2024 of the CFM aims to regulate the physician-healthcare industry relationship by prioritizing a transparent and...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-09-13-08-00-32-527-66e3f1207b0e94b9f9480703.jpg)
Decoding the regulatory conundrum Biopharmaceutical companies are navigating an increasingly complex global regulatory landscape that...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-09-11-14-05-22-574-66e1a3a2fd5f6342208d14c9.jfif)
The implications of the recent Illumina/Grail Judgment Executive Summary In a landmark EU judgment, on 3 September 2024, the Court of...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-09-09-16-56-46-041-66df28ce097b7a1aca18cbd0.jpg)
Regulatory AIFA updates Guidelines for the classification and conduct of observational studies on medicines On 20 August 2024, the...
